Protein Complex Structure Prediction Background
Proteins are dynamic entities, and their native state is determined by their sequence of amino acids. However, a single protein can adopt multiple conformations depending on its environment, such as a change in temperature. These conformations can reflect flexible regions, interactions within protein complexes, or transitions between active and inactive states.
Protai, a member of the NVIDIA Inception program for startups, aims to capture the structural changes between different protein states to determine the most precise protein structure for a specific mechanism of action (MOA), rather than settling for one conformation that may not be the most therapeutically relevant.
Protai is pushing the boundaries of drug discovery by leveraging Mass Spectrometry Proteomics and AI to develop precision medicine solutions that make a real difference for human health and society. At the core of Protai’s platform is a protein structure prediction pipeline, which integrates Nobel-winning protein structure algorithms, physics-based tools, and proprietary proteomics data.
Case Study: Predicting the H3-H4 Protein Complex
To illustrate Protai’s capabilities, this section examines the prediction of a…
Output
The AlphaFold2-Multimer NIM output in the Protein Data Bank (PDB) format contains atomic-level structural information about predicted protein multimers. In the output file, each atom of the protein is described using a structured format that adheres to the PDB format specification.
Conclusion
Protai’s structure prediction workflow combines the AlphaFold2-Multimer NIM, together with unique XL-MS linkers identified experimentally. By leveraging the NVIDIA optimized AI infrastructure, Protai accelerated predictions and improved scalability. This enables exploration of previously inaccessible protein interactions, opening new frontiers in drug discovery and precision medicine.
Frequently Asked Questions
Q1: What is Protai’s approach to protein structure prediction?
A1: Protai’s approach combines advanced computational algorithms with unique experimental data to predict protein structures and capture structural changes between different protein states.
Q2: What is XL-MS, and how does it contribute to Protai’s workflow?
A2: XL-MS is a powerful experimental technique that uses chemical cross-linkers to covalently bond specific amino acid residues within or between proteins, capturing spatial proximity and interaction sites. Protai combines XL-MS data with advanced sampling techniques and molecular dynamics simulations to generate protein structures that go beyond what’s currently available in the public domain.
Q3: How does NVIDIA NIM contribute to Protai’s workflow?
A3: NVIDIA NIM provides optimized AI infrastructure for drug discovery, enabling Protai to accelerate predictions and improve scalability while maintaining accuracy. This allows for the exploration of previously inaccessible protein interactions, opening new frontiers in drug discovery and precision medicine.
Q4: What are the potential applications of Protai’s technology?
A4: Protai’s technology has the potential to revolutionize drug discovery, enabling the development of precision medicine solutions that make a real difference for human health and society.
